Consensus process.
Use of follow-on disease-modifying treatments for multiple sclerosis: Consensus recommendations (Mult Scler. 2022 Dec;28(14):2177-2189.). Coordination of the consensus group, contribution to the systematic literature review and the revision of the manuscript. This project was funded by unrestricted educational grants from Viatris, Synthon and GL Pharma.